R. Pertwee

Pharmacology · 2002–2010

A researcher in the Science corpus: 8 papers; trusts 9 researchers and is trusted by 23 researchers here, as inferred from the citation graph.

Subfields

• Pharmacology — 56 citations into it; #40 of 1,112 by trust here, #150 by citations
• Cellular and Molecular Neuroscience — 35 citations into it; #422 of 2,998 by trust here, #938 by citations
• Cognitive Neuroscience — 21 citations into it; #10,776 of 10,852 by trust here, #3,702 by citations
• Endocrine and Autonomic Systems — 17 citations into it
• Sensory Systems — 11 citations into it
• Surgery — 6 citations into it

Whom R. Pertwee trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Allyn C. Howlett
2. R. Ross
3. A. Kreitzer
4. Wade G. Regehr
5. K. Mackie
6. S. Jordt
7. M. Guzmán
8. L. Iversen
9. Masanobu Kano
10. R. Mechoulam

Who trusts R. Pertwee overall

1. V. Di Marzo
2. M. Castaneto
3. Allyn C. Howlett
4. R. Ross
5. Shenglong Zou
6. D. Gorelick
7. I. Katona
8. M. Abood
9. P. Castillo
10. Stephen P. H. Alexander

Papers from R. Pertwee's perspective

Ordered by how strongly the researchers R. Pertwee trusts endorse each paper. Same corpus, a different order for every researcher.

1. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide (British Journal of Pharmacology)
2. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (Proceedings of the National Academy of Sciences of the United States of America)
3. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. (Neuron)
4. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. (Neuron)
5. Cannabinoid receptors and their ligands. (Prostaglandins, Leukotrienes and Essential Fatty Acids)
6. Modulation of transmitter release via presynaptic cannabinoid receptors. (TIPS - Trends in Pharmacological Sciences)
7. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro (British Journal of Pharmacology)
8. The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids* (Journal of Biological Chemistry)
9. The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids* (Journal of Biological Chemistry)
10. The Nuclear Receptor Peroxisome Proliferator-Activated Receptor-α Mediates the Anti-Inflammatory Actions of Palmitoylethanolamide (Molecular Pharmacology)

Their papers

• Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro (2007) — 765 citations
• International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (2010) — 1,739 citations
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin (2008) — 1,681 citations
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. (2008) — 733 citations
• Cannabinoid pharmacology: the first 66 years (2006) — 702 citations
• Pharmacological actions of cannabinoids. (2005) — 625 citations
• Cannabinoid receptors and their ligands. (2002) — 595 citations
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors (2002) — 2,760 citations